vs
Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Arteris, Inc. (AIP). Click either name above to swap in a different company.
ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $20.1M, roughly 1.1× Arteris, Inc.). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs 30.0%). Over the past eight quarters, Arteris, Inc.'s revenue compounded faster (24.7% CAGR vs 13.7%).
ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.
Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...
ADCT vs AIP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $23.1M | $20.1M |
| Net Profit | — | $-8.5M |
| Gross Margin | — | 90.8% |
| Operating Margin | -77.7% | -42.0% |
| Net Margin | — | -42.2% |
| Revenue YoY | 36.4% | 30.0% |
| Net Profit YoY | — | -3.7% |
| EPS (diluted) | $0.04 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.1M | $20.1M | ||
| Q3 25 | $15.8M | $17.4M | ||
| Q2 25 | $18.1M | $16.5M | ||
| Q1 25 | $17.4M | $16.5M | ||
| Q4 24 | $16.9M | $15.5M | ||
| Q3 24 | $18.0M | $14.7M | ||
| Q2 24 | $17.0M | $14.6M | ||
| Q1 24 | $17.8M | $12.9M |
| Q4 25 | — | $-8.5M | ||
| Q3 25 | $-41.0M | $-9.0M | ||
| Q2 25 | $-56.6M | $-9.1M | ||
| Q1 25 | $-38.6M | $-8.1M | ||
| Q4 24 | — | $-8.2M | ||
| Q3 24 | $-44.0M | $-7.7M | ||
| Q2 24 | $-36.5M | $-8.3M | ||
| Q1 24 | $-46.6M | $-9.4M |
| Q4 25 | — | 90.8% | ||
| Q3 25 | — | 89.9% | ||
| Q2 25 | — | 89.4% | ||
| Q1 25 | — | 90.8% | ||
| Q4 24 | — | 89.8% | ||
| Q3 24 | — | 90.1% | ||
| Q2 24 | — | 90.0% | ||
| Q1 24 | — | 88.7% |
| Q4 25 | -77.7% | -42.0% | ||
| Q3 25 | -196.6% | -50.1% | ||
| Q2 25 | -244.1% | -50.0% | ||
| Q1 25 | -163.5% | -46.6% | ||
| Q4 24 | -191.8% | -45.9% | ||
| Q3 24 | -197.4% | -53.8% | ||
| Q2 24 | -170.5% | -51.1% | ||
| Q1 24 | -188.3% | -70.5% |
| Q4 25 | — | -42.2% | ||
| Q3 25 | -260.1% | -51.6% | ||
| Q2 25 | -313.2% | -55.3% | ||
| Q1 25 | -221.8% | -49.1% | ||
| Q4 24 | — | -53.0% | ||
| Q3 24 | -244.1% | -52.2% | ||
| Q2 24 | -214.6% | -57.2% | ||
| Q1 24 | -261.1% | -72.6% |
| Q4 25 | $0.04 | $-0.19 | ||
| Q3 25 | $-0.30 | $-0.21 | ||
| Q2 25 | $-0.50 | $-0.22 | ||
| Q1 25 | $-0.36 | $-0.20 | ||
| Q4 24 | $-0.26 | $-0.19 | ||
| Q3 24 | $-0.42 | $-0.20 | ||
| Q2 24 | $-0.38 | $-0.22 | ||
| Q1 24 | $-0.56 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $261.3M | $33.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-185.8M | $-14.6M |
| Total Assets | $323.1M | $115.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $261.3M | $33.9M | ||
| Q3 25 | $234.7M | $39.0M | ||
| Q2 25 | $264.6M | $38.0M | ||
| Q1 25 | $194.7M | $42.3M | ||
| Q4 24 | $250.9M | $43.8M | ||
| Q3 24 | $274.3M | $48.7M | ||
| Q2 24 | $300.1M | $45.8M | ||
| Q1 24 | $234.3M | $44.8M |
| Q4 25 | $-185.8M | $-14.6M | ||
| Q3 25 | $-238.2M | $-11.4M | ||
| Q2 25 | $-199.2M | $-7.5M | ||
| Q1 25 | $-238.2M | $-4.8M | ||
| Q4 24 | $-202.6M | $-1.2M | ||
| Q3 24 | $-171.9M | $2.2M | ||
| Q2 24 | $-131.7M | $5.3M | ||
| Q1 24 | $-194.4M | $9.5M |
| Q4 25 | $323.1M | $115.0M | ||
| Q3 25 | $289.8M | $107.7M | ||
| Q2 25 | $321.6M | $106.9M | ||
| Q1 25 | $272.5M | $98.3M | ||
| Q4 24 | $322.0M | $106.1M | ||
| Q3 24 | $349.1M | $97.7M | ||
| Q2 24 | $371.8M | $96.4M | ||
| Q1 24 | $308.0M | $101.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-31.1M | $3.2M |
| Free Cash FlowOCF − Capex | — | $3.0M |
| FCF MarginFCF / Revenue | — | 15.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-31.1M | $3.2M | ||
| Q3 25 | $-29.6M | $3.2M | ||
| Q2 25 | $-24.1M | $-2.5M | ||
| Q1 25 | $-56.3M | $2.9M | ||
| Q4 24 | $-21.9M | $-2.6M | ||
| Q3 24 | $-25.0M | $1.1M | ||
| Q2 24 | $-32.8M | $311.0K | ||
| Q1 24 | $-44.1M | $477.0K |
| Q4 25 | — | $3.0M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $-2.8M | ||
| Q1 25 | $-56.6M | $2.7M | ||
| Q4 24 | $-21.9M | $-2.7M | ||
| Q3 24 | $-25.3M | $1.1M | ||
| Q2 24 | $-32.9M | $264.0K | ||
| Q1 24 | $-44.6M | $281.0K |
| Q4 25 | — | 15.1% | ||
| Q3 25 | — | 14.2% | ||
| Q2 25 | — | -17.2% | ||
| Q1 25 | -325.2% | 16.2% | ||
| Q4 24 | -129.8% | -17.3% | ||
| Q3 24 | -140.2% | 7.4% | ||
| Q2 24 | -193.0% | 1.8% | ||
| Q1 24 | -250.0% | 2.2% |
| Q4 25 | 0.0% | 0.7% | ||
| Q3 25 | 0.0% | 4.1% | ||
| Q2 25 | 0.0% | 2.2% | ||
| Q1 25 | 1.5% | 1.1% | ||
| Q4 24 | 0.5% | 0.3% | ||
| Q3 24 | 1.2% | 0.2% | ||
| Q2 24 | 0.2% | 0.3% | ||
| Q1 24 | 3.0% | 1.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADCT
Segment breakdown not available.
AIP
| License And Maintenance | $17.5M | 87% |
| Variable Royalties And Other | $2.6M | 13% |